Back

The Notch1/Delta-like-4 axis is crucial for the initiation and progression of oral squamous cell carcinoma

Meisel, C. T.; Destefani, R.; Valookkaran, I. J.; Batavia, A.; Rupp, N.; Porcheri, C.; Mitsiadis, T.

2024-01-24 cancer biology
10.1101/2024.01.21.576524 bioRxiv
Show abstract

The Notch signaling pathway is frequently altered in oral squamous cell carcinoma (OSCC), the most common malignant neoplasm of the oral mucosa. This study aimed to elucidate the functional role of this pathway in both the initiation and progression of OSCC. Using transgenic animal models, advanced imaging, and next-generation-sequencing techniques, we analyzed Notch-dependent changes driving OSCC. We found specific expression patterns of Notch1 and Delta-like-4 confined to the malignant tissue, while Jagged1 was downregulated in OSCC. This mutually exclusive expression of Delta-like-4 and Jagged1 occurs at the early hyperplastic stage and persists until more advanced stages of the developing tumor. Transcriptomic analyses confirmed the dysregulation of the Notch pathway circuitry and of the genes associated with the undifferentiated state of OSCC cells. Furthermore, pharmacological Notch inhibition significantly impaired cancer cell motility. Taken together, these results reveal the pivotal importance of the Notch1/Delta-like-4 signaling axis as a central oncogenic driver in OSCC. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=112 SRC="FIGDIR/small/576524v1_ufig1.gif" ALT="Figure 1"> View larger version (15K): org.highwire.dtl.DTLVardef@dcaf6corg.highwire.dtl.DTLVardef@811036org.highwire.dtl.DTLVardef@14f5aecorg.highwire.dtl.DTLVardef@da6087_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Cancers
200 papers in training set
Top 0.1%
33.0%
2
Scientific Reports
3102 papers in training set
Top 27%
4.3%
3
Frontiers in Oncology
95 papers in training set
Top 0.8%
4.3%
4
Molecular Oncology
50 papers in training set
Top 0.1%
4.3%
5
Oncogene
76 papers in training set
Top 0.5%
3.6%
6
eLife
5422 papers in training set
Top 25%
3.6%
50% of probability mass above
7
Disease Models & Mechanisms
119 papers in training set
Top 0.5%
3.6%
8
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 2%
3.3%
9
British Journal of Cancer
42 papers in training set
Top 0.6%
2.1%
10
International Journal of Cancer
42 papers in training set
Top 0.6%
1.8%
11
Cell Reports
1338 papers in training set
Top 24%
1.7%
12
Cell Communication and Signaling
35 papers in training set
Top 0.4%
1.7%
13
PLOS ONE
4510 papers in training set
Top 57%
1.5%
14
Cells
232 papers in training set
Top 3%
1.3%
15
International Journal of Molecular Sciences
453 papers in training set
Top 11%
1.2%
16
Oncotarget
15 papers in training set
Top 0.2%
1.2%
17
Communications Biology
886 papers in training set
Top 16%
1.1%
18
Molecular Cancer
14 papers in training set
Top 0.7%
1.0%
19
iScience
1063 papers in training set
Top 27%
0.9%
20
Journal of Experimental & Clinical Cancer Research
25 papers in training set
Top 0.2%
0.9%
21
EMBO Molecular Medicine
85 papers in training set
Top 4%
0.7%
22
Nature Communications
4913 papers in training set
Top 63%
0.7%
23
Frontiers in Molecular Biosciences
100 papers in training set
Top 5%
0.7%
24
Experimental Dermatology
10 papers in training set
Top 0.3%
0.7%
25
Computational Biology and Chemistry
23 papers in training set
Top 0.6%
0.7%
26
Human Genomics
21 papers in training set
Top 0.4%
0.7%
27
The Journal of Pharmacology and Experimental Therapeutics
15 papers in training set
Top 0.5%
0.7%
28
JCI Insight
241 papers in training set
Top 8%
0.7%
29
European Journal of Nuclear Medicine and Molecular Imaging
19 papers in training set
Top 0.3%
0.7%
30
Acta Neuropathologica Communications
81 papers in training set
Top 1%
0.6%